sasaki osamu

Affiliation and department：
Research theme for competitive and other funds (1)：

2013 - 2016 Analysis of transformation processes by using the "two-hit leukemogenesis model"

Papers (17)：

Masaharu Shinkai, Noriyuki Katsumata, Shinichi Kawai, Shoichi Kuyama, Osamu Sasaki, Yasuhiro Yanagita, Minoru Yoshida, Shima Uneda, Yasushi Tsuji, Hidenori Harada, et al. Phase III study of bilayer sustained-release tramadol tablets in patients with cancer pain: a double-blind parallel-group, non-inferiority study with immediate-release tramadol capsules as an active comparator. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2023. 32. 1. 69-69
Akira Matsuda, Kazunori Imada, Naoshi Obara, Hiroatsu Iida, Hirohito Yamazaki, Yoshiaki Tomiyama, Koichi Miyamura, Osamu Sasaki, Tetsuo Maeda, Kensuke Ohta, et al. Dysmegakaryopoiesis and Transient Mild Increase in Bone Marrow Blasts in Patients With Aplastic Anemia Treated With Eltrombopag May Be Signs of Hematologic Improvement and Not Portend Clonal Evolution. American journal of clinical pathology. 2022. 158. 5. 604-615
Atae Utsunomiya, Koji Izutsu, Tatsuro Jo, Shinichiro Yoshida, Kunihiro Tsukasaki, Kiyoshi Ando, Ilseung Choi, Yoshitaka Imaizumi, Koji Kato, Mitsutoshi Kurosawa, et al. Oral histone deacetylase inhibitor tucidinostat (HBI-8000) in patients with relapsed or refractory adult T-cell leukemia/lymphoma: Phase IIb results. Cancer science. 2022. 113. 8. 2778-2787
Yasushi Onishi, Hisayuki Yokoyama, Yuna Katsuoka, Toshihiro Ito, Tomohumi Kimura, Joji Yamamoto, Shinji Nakajima, Osamu Sasaki, Takahide Ara, Koichiro Minauchi, et al. Low-dose lenalidomide and dexamethasone therapy after melphalan-prednisolone induction in elderly patients with newly diagnosed multiple myeloma. Annals of hematology. 2020. 99. 10. 2351-2356
Kenshi Suzuki, Noriko Doki, Kuniaki Meguro, Kazutaka Sunami, Hiroshi Kosugi, Osamu Sasaki, Toshiyuki Takagi, Hirokazu Murakami, Kazuyuki Shimizu. Report of phase I and II trials of melphalan, prednisolone, and thalidomide triplet combination therapy versus melphalan and prednisolone doublet combination therapy in Japanese patients with newly diagnosed multiple myeloma ineligible for autologous stem cell transplantation. International journal of hematology. 2019. 110. 4. 447-457

ｍore...

MISC (18)：

小松弘香, 鎌田真弓, 斎藤陽, 原崎頼子, 遠宮靖雄, 佐々木治. Daratumumab投与後に溶血性貧血を来した多発性骨髄腫の1例. 臨床血液. 2024. 65. 4. 282-282
小松弘香, 斎藤陽, 鎌田真弓, 原崎頼子, 遠宮靖雄, 佐々木治. Pola+BR療法により完全奏効を得た,第2再発期の血管内大細胞型B細胞リンパ腫の1例. 臨床血液. 2023. 64. 10. 1358-1359
鎌田真弓, 原崎頼子, 遠宮靖雄, 佐々木治. 本態性血小板血症の経過中にB細胞リンパ芽球性白血病を発症した1例. 臨床血液. 2022. 63. 5. 490-490
門馬仁美, 後藤夕子, 佐々木理衣, 高山玲子, 大石幸子, 佐藤千賀, 宮内奈央子, 土屋雅美, 渡邊香奈, 村川康子, et al. 宮城県立がんセンターにおける外来化学療法室の運用に向けた取り組み. 日本癌治療学会学術集会抄録集. 2021. 59回. P47-5
鎌田真弓, 原崎頼子, 遠宮靖雄, 佐々木治. 当センターにおける濾胞性リンパ腫の早期死亡の解析(Analysis of early death in follicular lymphoma: a single center retrospective study). 日本血液学会学術集会. 2021. 83回. PS-3

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page